Nanotechnology as a therapeutic tool to combat microbial resistance.
暂无分享,去创建一个
[1] Advances in industrial biofilm control with micro-nanotechnology , 2011 .
[2] E. Stobberingh,et al. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. , 2009, Current molecular medicine.
[3] A. Friedman,et al. The growing role of nanotechnology in combating infectious disease , 2011, Virulence.
[4] Young Jik Kwon,et al. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[5] P. Courvalin,et al. VanA-Type Vancomycin-Resistant Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.
[6] T. Triglia,et al. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. W. Young,et al. In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. , 2012, The Journal of antimicrobial chemotherapy.
[8] J. Friedman,et al. Nitric oxide releasing nanoparticle synthesis and characterization. , 2011, Methods in molecular biology.
[9] K. Poole. Mechanisms of bacterial biocide and antibiotic resistance. , 2002, Symposium series.
[10] J. Friedman,et al. Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection , 2009, PloS one.
[11] M. Vayssier-Taussat,et al. Transmission of Bartonella henselae by Ixodes ricinus , 2008, Emerging infectious diseases.
[12] M. Vieira,et al. A review of current and emergent biofilm control strategies , 2010 .
[13] K. Arévalo-Niño,et al. Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm , 2012, International journal of nanomedicine.
[14] J. Davies,et al. Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.
[15] R. Proctor. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] H. Chambers,et al. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. , 1999, The Journal of infectious diseases.
[17] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[18] Liyuan Ma,et al. Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria. , 2013, Nanoscale.
[19] Adam J. Friedman,et al. The potential of nitric oxide releasing therapies as antimicrobial agents , 2012, Virulence.
[20] P. Gao,et al. Recent advances in materials for extended-release antibiotic delivery system , 2011, The Journal of Antibiotics.
[21] Adam J Friedman,et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. , 2009, The Journal of investigative dermatology.
[22] A. Friedman,et al. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens , 2012, The Journal of investigative dermatology.
[23] A. Robicsek,et al. Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme , 2006, Antimicrobial Agents and Chemotherapy.
[24] L. R. Martinez. Nitric oxide-releasing nanoparticles: challenges and future prospects. , 2012, Therapeutic delivery.
[25] Buchang Zhang,et al. Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera , 2012, Proceedings of the National Academy of Sciences.
[26] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[27] L. Martínez-Martínez,et al. Mutational analysis of quinolone resistance in the plasmid-encoded pentapeptide repeat proteins QnrA, QnrB and QnrS. , 2009, The Journal of antimicrobial chemotherapy.
[28] Sherine O. Obare,et al. Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus , 2012, Applied and Environmental Microbiology.
[29] J. Friedman,et al. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections , 2010, Virulence.
[30] M. Schoenfisch,et al. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. , 2009, Biomaterials.
[31] B. Gibbins,et al. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.
[32] Leo H. Koole,et al. New Strategies in the Development of Antimicrobial Coatings: The Example of Increasing Usage of Silver and Silver Nanoparticles , 2011 .
[33] A. Ditto,et al. The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. , 2009, Biomaterials.
[34] R. Quintiliani. Using pharmacodynamic and pharmacokinetic concepts to optimize treatment of infectious diseases , 2004 .
[35] S. Levy,et al. Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.
[36] J. Friedman,et al. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. , 2011, Nitric oxide : biology and chemistry.
[37] Chun-Ming Huang,et al. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. , 2011, Biomaterials.
[38] Ian G. Macreadie,et al. Dihydropteroate Synthase Mutations in Pneumocystis jiroveci Can Affect Sulfamethoxazole Resistance in a Saccharomyces cerevisiae Model , 2004, Antimicrobial Agents and Chemotherapy.
[39] A. Ficai,et al. Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development , 2012, Nanoscale Research Letters.
[40] L. H. Hansen,et al. The macrolide–ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA , 1999, Molecular microbiology.
[41] Chun-Ming Huang,et al. Development of nanoparticles for antimicrobial drug delivery. , 2010, Current medicinal chemistry.
[42] J. Friedman,et al. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology , 2011, Virulence.
[43] J. Friedman,et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. , 2008, Nitric oxide : biology and chemistry.
[44] A. Alanis,et al. Resistance to antibiotics: are we in the post-antibiotic era? , 2005, Archives of medical research.
[45] B. Ratner,et al. Bioinspired implant materials befuddle bacteria , 2004 .
[46] Michael R Hamblin,et al. Synergistic Combination of Chitosan Acetate with Nanoparticle Silver as a Topical Antimicrobial: Efficacy against Bacterial Burn Infections , 2011, Antimicrobial Agents and Chemotherapy.
[47] G. Jacoby,et al. Updated Functional Classification of β-Lactamases , 2009, Antimicrobial Agents and Chemotherapy.
[48] P. Higgins,et al. Fluoroquinolones: structure and target sites. , 2003, Current drug targets.
[49] A. Robicsek,et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase , 2006, Nature Medicine.
[50] Morteza Mahmoudi,et al. Antibacterial properties of nanoparticles. , 2012, Trends in biotechnology.
[51] A. Grumezescu,et al. Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity , 2012, Nanoscale Research Letters.
[52] S. M. Robinson,et al. Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. , 2012, Biochemical Society transactions.
[53] Susan E. Brown,et al. Isothermal Amplification and Molecular Typing of the Obligate Intracellular Pathogen Mycobacterium leprae Isolated from Tissues of Unknown Origins , 2006, Journal of Clinical Microbiology.
[54] Malcolm N. Jones,et al. The Delivery of Benzyl Penicillin to Staphylococcus aureus Biofilms by Use of Liposomes , 2004, Journal of liposome research.
[55] M. Schoenfisch,et al. Examination of bacterial resistance to exogenous nitric oxide. , 2012, Nitric oxide : biology and chemistry.
[56] A. Gedanken,et al. Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles , 2012, International journal of nanomedicine.
[57] Cristina Rodríguez Padilla,et al. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria , 2010 .
[58] R. Jayaraman,et al. Antibiotic resistance: an overview of mechanisms and a paradigm shift , 2009 .
[59] J. Friedman,et al. Nitric oxide nanoparticles , 2012, Virulence.
[60] T. Hackstadt,et al. The diverse habitats of obligate intracellular parasites. , 1998, Current opinion in microbiology.
[61] Nikokar Iraj,et al. Effects of Salt Stress on the Antimicrobial Drug Resistance and Protein Profile of Staphylococcus aureus , 2012 .
[62] R. Humphries,et al. The emerging problem of linezolid-resistant Staphylococcus. , 2013, The Journal of antimicrobial chemotherapy.